LYNPARZA 150MG TABLET
Form: Tablets
Pack Size: 8 TABLETS
Marketed by: ASTRAZENECA PHARMA INDIA LTD (ONCOLOGY DIV)
MRP: ₹41025.00
ASTRAZENECA PHARMA INDIA LTD (ONCOLOGY DIV): Lynparza 150MG Tablet, 8 tablets, salt olaparib 150mg. Its MRP stays at Rs 41,025 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 31,257.14. Group: PARP inhibitor (targeted therapy). Same salt is also supplied by Abbott, Cipla, Dr. Reddy's, Emcure, Glenmark and others. Handling/counselling: tablet and capsule forms are not interchangeable mg for mg; check the prescription carefully. Schedule H - supply only to licensed buyers and dispense only on prescription.
Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.